medigraphic.com

2014, Number 4

<< Back Next >>

Rev Med Inst Mex Seguro Soc 2014; 52 (4)

Registry of myocardial infarction in a tertiary hospital of the Instituto Mexicano del Seguro Social

González-Pliego JA, Gudiño-Amezcua DA, Celis A, Gutiérrez-Díaz GI

Language: Spanish
References: 23
Page: 382-387
PDF size: 185.42 Kb.


ABSTRACT

Background: Since the prognosis of myocardial infarction with ST elevation (STEMI) depends on its immediate handling and on secondary prevention measures, not following the recommendations could impede the improvement of the population affected by this disease. The aim was to describe the clinical-epidemiologic profi le and the process of care of patients with STEMI in a tertiary hospital.
Methods: We analyzed the clinical information, the risk stratifi cation, the revascularization therapy and the prescription trends at discharge of patients with STEMI attended in one year.
Results: 246 patients with a mean age of 61 years were included; 76 % were men. Most of the cases of STEMI (37.3 %) were patients from 60 to 69 years. The most prevalent risk factor was sedentarism. The TIMI score was low in 81.7 % of the cases. Residual ischemia/viability was detected in 35 %, and coronary obstructions were found in all the cases of catheterized patients. Percutaneous coronary intervention was carried out in 76 %, mainly with drug-eluting stents (77.5 %). At discharge, statins and antiplatelet agents were prescribed in more than 90 %; other drugs were prescribed to 64-82 % of the cases.
Conclusions: STEMI predominates in sedentary men over 60 years. Using stents to stratify risk, to look for residual ischemia/viability, and to revascularize with drug-eluting are common practices, but the compliance of evidence-based guidelines, although better than in the past, is not optimal yet.


REFERENCES

  1. Antman EM, Hand M, Armstrong PW, Bates ER, Green LA, Halasyamani LK, et al. 2007 focused update of the ACC/AHA 2004 Guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/ American Heart Association task force on practice guidelines developed in collaboration with the Canadian Cardiovascular Society endorsed by the American Academy of Family Physicians. Circulation. 2008;117(2):296-329.

  2. Steg G, James SK, Atar D, Banado LP, Blömstrom- Lundqvist C, Borger MA, et al. ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. The task force on the management of ST-segment elevation myocardial infarction of the European SoRev Med Inst Mex Seguro Soc. 2014;52(4):382-7 387 González-Pliego JA et al. Registro hospitalario de infarto del miocardio ciety of Cardiology (ESC). Eur Heart J. 2012;33(20): 2569-619.

  3. Grupo de trabajo de la Sociedad Española de Cardiología para la guía de práctica clínica sobre el síndrome coronario agudo con elevación del segmento ST. Grupo de revisores expertos para la guía del síndrome coronario agudo con elevación del segmento ST. Comité de guías de práctica clínica de la Sociedad Española de Cardiología. Comentarios a la guía de práctica clínica de la ESC para el manejo del infarto agudo del miocardio en pacientes con elevación del segmento ST. Rev Esp Cardiol. 2013; 66(1):5-11.

  4. Lupi HE. Por el Grupo Cooperativo RENASICA. El Registro Nacional de Síndromes Coronarios Agudos (RENASICA). Sociedad Mexicana de Cardiología. Arch Cardiol Mex. 2002;72(Supl. 2):S45-S64.

  5. Sistema Nacional de Información en Salud (SINAIS). Principales causas de mortalidad general 2008. Disponible en www.sinais.salud.gob.mx/descargas/ xls/m_005.xls

  6. García-Castillo A. Por los investigadores del Registro Nacional de Síndromes Coronarios agudos II (RENASICA II). Arch Cardiol Mex. 2005;75 (Supl.1): S6-S19.

  7. Granger CB, Goldberg RJ, Dabbous O, Pieper KS, Eagle KA, Cannon CP, et al. Predictors of hospital mortality in the Global Registry of Acute Coronary Events. Arch Intern Med. 2003;163(19):2345-53.

  8. Borrayo-Sánchez G, Madrid-Miller A, Arriaga-Nava A, Ramos-Corrales MA, García-Aguilar J, Almeida- Gutiérrez E. Riesgo estratifi cado de los síndromes coronarios agudos. Resultados del primer Renasca- IMSS. Rev Med Inst Mex Seguro Soc. 2010;48(3): 259-64.

  9. Mendis S, Thygesen K, Kuulasmaa K, Giampaoli S, Mähönen M, Ngu BK, et al, and writing group on behalf of the participating experts of the WHO consultation for revision of WHO defi nition of myocardial infarction. World Health Organization defi nition of myocardial infarction: 2008-09 revision. Int J Epidemiol. 2010;40(1):139-46.

  10. Killip T III, Kimball JT. Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients. Am J Cardiol. 1967;20(4):457-64.

  11. Morrow DA, Antman EM, Charlesworth A, Cairns R, Murphy SA, de Lemos JA, et al. TIMI risk score for ST-elevation myocardial infarction: A convenient, bedside, clinical score for risk assessment at presentation: An intravenous nPA for treatment of infarcting myocardium early II trial substudy. Circulation. 2000;102(17):2031-7.

  12. Escobedo-de la Peña J, Rodríguez-Ábrego G, Buitrón-Granados LV. Morbilidad y mortalidad por cardiopatía isquémica en el Instituto Mexicano del Seguro Social. Estudio ecológico de tendencias en población amparada por el Instituto Mexicano del Seguro Social entre 1990 y 2008. Arch Cardiol Mex. 2010;80(4):242-8.

  13. Lanas F, Avezum A, Bautista LE, Diaz R, Luna M, Islam S, et al. Risk factors for acute myocardial infarction in Latin America. The INTERHEART Latin American study. Circulation. 2007;115(9):1067-74.

  14. Smith SC. Risk factors for myocardial infarction in Latin America. Sobrepeso y obesidad. Circulation. 2007;115(9):1061-3.

  15. Morrow DA, Antman EM, Parsons L, de Lemos JA, Cannon CP, Giugliano RP, et al. Application of the TIMI risk score for ST-elevation MI in the National Registry of Myocardial Infarction 3. JAMA. 2001; 286(11):1356-9.

  16. González-Pacheco H, Arias-Mendoza A, Álvarez- Sangabriel A, Juárez-Herrera U, Damas F, Eid-Lidt G, et al. The TIMI risk score for STEMI predicts inhospital mortality and adverse events in patients without cardiogenic shock undergoing primary angioplasty. Arch Cardiol Mex. 2012;82(1):7-13.

  17. Anavekar NS, McMurray JJ, Velazquez EJ, Solomon SD, Kober L, Rouleau JL, et al. Relation between renal disfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med. 2004;351(13):1285-95.

  18. Arós F, Cuñat J, Loma-Osorio A, Torrado E, Bosch X, Rodríguez JJ, et al. PRIAMHO II study. Tratamiento del infarto agudo del miocardio en España en el año 2000. El estudio PRIAMHO. Rev Esp Cardiol. 2003;56(12):1165-73.

  19. Alpert JS, Simons M, Douglas PS, Wilson PW, Breall JA. Risk stratifi cation after acute ST-elevation myocardial infarction. Up to date. Disponible en http:// www.uptodate.com/contents/risk-stratifi cation-afteracute- st-elevation-myocardial-infarction

  20. Moreno R. Manejo del infarto agudo del miocardio en España. Diferencias interregionales en la actualidad según el registro IBERICA. Rev Esp Cardiol. 2001;54(4):419-21.

  21. Dacanay S, Kennedy HL, Uretz E, Parrillo JE, Klein LW. Morphological and quantitative angiographic analyses of progression of coronary stenoses. A comparison of Q-wave and non-Q-wave myocardial infarction. Circulation. 1994;90(4):1739-46.

  22. Mauri L, Silbaugh TS, Garg P, Wolf RE, Zelevinsky K, Lovett A, et al. Drug-eluting or bare-metal stents for acute myocardial infarction. New Engl J Med. 2008; 359(13):1330-42.

  23. Smith SC, Benjamin EJ, Bonow RO, Braun LT, Creager MA, Franklin BA, et al. AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular diseases: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation. Circulation. 2011;124(19):2458-73.




2020     |     www.medigraphic.com